<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>FAPEX: Fractional Amplitude-Phase Expressor for Robust Cross-Subject Seizure Prediction - Health AI Hub</title>
    <meta name="description" content="FAPEX introduces a novel architecture featuring a fractional neural frame operator (FrNFO) for adaptive time-frequency decomposition, addressing the challenge o">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>FAPEX: Fractional Amplitude-Phase Expressor for Robust Cross-Subject Seizure Prediction</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.03263v1" target="_blank">2511.03263v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-05
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Ruizhe Zheng, Lingyan Mao, Dingding Han, Tian Luo, Yi Wang, Jing Ding, Yuguo Yu
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> q-bio.NC, eess.SP
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.03263v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="http://arxiv.org/pdf/2511.03263v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">FAPEX introduces a novel architecture featuring a fractional neural frame operator (FrNFO) for adaptive time-frequency decomposition, addressing the challenge of robust subject-agnostic seizure prediction (SASP). By capturing a full range of electrophysiological dynamics and integrating structural state-space modeling, FAPEX achieves significant performance improvements (up to 15% sensitivity) and superior generalization across diverse species and recording modalities. This advancement offers a promising solution for discovering preictal biomarkers and facilitating clinical translation in epilepsy management.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Precise and generalizable seizure prediction can dramatically improve the quality of life for epilepsy patients by enabling timely interventions, enhancing patient safety, and guiding personalized therapeutic strategies. The ability to robustly identify a preictal state across diverse patient populations and data types is critical for developing preventative measures and a deeper understanding of seizure mechanisms.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>FAPEX is an AI model developed for Subject-Agnostic Seizure Prediction (SASP) using electrophysiological data. Its application would involve real-time monitoring and prediction of epileptic seizures, enabling timely interventions, improving patient safety, and aiding in the discovery of novel preictal biomarkers that could inform therapeutic strategies and understand the underlying mechanisms of epilepsy.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>FAPEX proposes a novel architecture using a learnable fractional neural frame operator (FrNFO) for adaptive time-frequency decomposition.</li>
                    
                    <li>The FrNFO employs fractional-order convolutions to capture both high and low-frequency electrophysiological dynamics, overcoming spectral bias toward low frequencies seen in conventional models.</li>
                    
                    <li>It extracts instantaneous phase and amplitude representations, which are crucial for preictal biomarker discovery and enhancing out-of-distribution generalization.</li>
                    
                    <li>FAPEX integrates structural state-space modeling and channelwise attention, enabling it to robustly handle heterogeneous electrode montages across different recording modalities.</li>
                    
                    <li>The model demonstrates significant performance gains, achieving approximately 10% improvement in F1-score and sensitivity over state-of-the-art baselines, and up to 15% sensitivity gain in complex cross-domain scenarios.</li>
                    
                    <li>Evaluated across 12 benchmarks, spanning human, rat, dog, and macaque, and modalities like Scalp-EEG, SEEG, ECoG, and LFP, FAPEX consistently outperformed 33 supervised and self-supervised baselines.</li>
                    
                    <li>This establishes FAPEX as a leading epilepsy model for SASP, offering strong evidence for a distinct preictal state and high potential for clinical translation.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>FAPEX is a novel neural architecture featuring a learnable fractional neural frame operator (FrNFO). The FrNFO utilizes fractional-order convolutions to perform adaptive time-frequency decomposition, allowing it to capture a wider range of electrophysiological signal dynamics (both high and low frequencies) than models with conventional convolutions. This process generates informative instantaneous phase and amplitude representations. The architecture further integrates structural state-space modeling and channelwise attention mechanisms to accommodate variability in electrode montages and recording modalities. The model's performance was rigorously evaluated using nested cross-validation across 12 diverse benchmarks, comparing it against 33 supervised and self-supervised baselines.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>FAPEX consistently demonstrated superior performance in subject-agnostic seizure prediction, achieving approximately 10% improvement in F1-score and sensitivity over existing state-of-the-art models. In challenging cross-domain prediction scenarios, it exhibited sensitivity gains of up to 15%. The model outperformed a total of 23 supervised and 10 self-supervised baselines across a wide array of species (human, rat, dog, macaque) and electrophysiological recording modalities (Scalp-EEG, SEEG, ECoG, LFP). Its performance was also validated in several external cohorts, indicating strong out-of-distribution generalization capabilities and establishing it as the first epilepsy model to show consistent superiority in SASP.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This research provides a powerful tool for robust and generalizable seizure prediction, potentially transforming epilepsy management. Clinically, it could lead to the development of highly reliable warning systems for patients, enabling them to anticipate and mitigate seizures, thereby reducing injury and improving independence. The model's ability to discover preictal biomarkers could accelerate research into the underlying mechanisms of epilepsy and facilitate the development of targeted preventative therapies. Its versatility across different data types and species suggests broad applicability in diverse clinical settings and for heterogeneous patient populations, paving the way for eventual clinical translation.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations of the FAPEX model itself; it primarily highlights its strengths and superior performance.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>While not explicitly detailing 'future directions,' the abstract indicates a primary goal of clinical translation. It aims to support 'discovering epileptic biomarker evidence supporting the existence of a distinct and identifiable preictal state and clinical translation,' suggesting ongoing efforts towards validating these biomarkers in clinical practice and integrating FAPEX into patient care workflows.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Neurology</span>
                    
                    <span class="tag">Epileptology</span>
                    
                    <span class="tag">Clinical Neurophysiology</span>
                    
                    <span class="tag">Biomedical Engineering</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Seizure prediction</span>
                    
                    <span class="tag tag-keyword">Epilepsy</span>
                    
                    <span class="tag tag-keyword">Electrophysiology</span>
                    
                    <span class="tag tag-keyword">Fractional convolution</span>
                    
                    <span class="tag tag-keyword">Time-frequency analysis</span>
                    
                    <span class="tag tag-keyword">Subject-agnostic</span>
                    
                    <span class="tag tag-keyword">Preictal biomarkers</span>
                    
                    <span class="tag tag-keyword">Deep learning</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Precise, generalizable subject-agnostic seizure prediction (SASP) remains a
fundamental challenge due to the intrinsic complexity and significant spectral
variability of electrophysiological signals across individuals and recording
modalities. We propose FAPEX, a novel architecture that introduces a learnable
fractional neural frame operator (FrNFO) for adaptive time-frequency
decomposition. Unlike conventional models that exhibit spectral bias toward low
frequencies, our FrNFO employs fractional-order convolutions to capture both
high and low-frequency dynamics, achieving approximately 10% improvement in
F1-score and sensitivity over state-of-the-art baselines. The FrNFO enables the
extraction of instantaneous phase and amplitude representations that are
particularly informative for preictal biomarker discovery and enhance
out-of-distribution generalization. FAPEX further integrates structural
state-space modeling and channelwise attention, allowing it to handle
heterogeneous electrode montages. Evaluated across 12 benchmarks spanning
species (human, rat, dog, macaque) and modalities (Scalp-EEG, SEEG, ECoG, LFP),
FAPEX consistently outperforms 23 supervised and 10 self-supervised baselines
under nested cross-validation, with gains of up to 15% in sensitivity on
complex cross-domain scenarios. It further demonstrates superior performance in
several external validation cohorts. To our knowledge, these establish FAPEX as
the first epilepsy model to show consistent superiority in SASP, offering a
promising solution for discovering epileptic biomarker evidence supporting the
existence of a distinct and identifiable preictal state and clinical
translation.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>39th Conference on Neural Information Processing Systems (NeurIPS
  2025) Spotlight Poster</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>